» Articles » PMID: 11083836

The Arginine Finger Domain of ExoT Contributes to Actin Cytoskeleton Disruption and Inhibition of Internalization of Pseudomonas Aeruginosa by Epithelial Cells and Macrophages

Overview
Journal Infect Immun
Date 2000 Nov 18
PMID 11083836
Citations 93
Authors
Affiliations
Soon will be listed here.
Abstract

Pseudomonas aeruginosa, an important nosocomial pathogen of humans, expresses a type III secretion system that is required for virulence. Previous studies demonstrated that the lung-virulent strain PA103 has the capacity to be either cytotoxic or invasive. Analyses of mutants suggest that PA103 delivers a negative regulator of invasion, or anti-internalization factor, to host cells via a type III secretion system. In this work we show that the type III secreted protein ExoT inhibits the internalization of PA103 by polarized epithelial cells (Madin-Darby canine kidney cells) and J774.1 macrophage-like cells. ExoS, which is closely related to ExoT but has additional ADP-ribosylating activity, can substitute for ExoT as an anti-internalization factor. ExoT contains a signature arginine finger domain found in GTPase-activating proteins. Mutation of the conserved arginine in ExoT diminished its anti-internalization activity and altered its ability to disrupt the actin cytoskeleton. Cell fractionation experiments showed that ExoT is translocated into host cells and that mutation of the arginine finger did not disrupt translocation. In a mouse model of acute pneumonia, PA103DeltaUDeltaT reached the lungs as efficiently as PA103DeltaU but showed reduced colonization of the liver. This finding suggests that the ability to resist internalization may be important for virulence in vivo.

Citing Articles

Establishment and characterization of persistent infections in air-liquid interface cultures of human airway epithelial cells.

Bouheraoua S, Cleeves S, Preusse M, Musken M, Braubach P, Fuchs M Infect Immun. 2025; 93(3):e0060324.

PMID: 39964154 PMC: 11895474. DOI: 10.1128/iai.00603-24.


Urinary tract infections and catheter-associated urinary tract infections caused by .

El Husseini N, Carter J, Lee V Microbiol Mol Biol Rev. 2024; 88(4):e0006622.

PMID: 39431861 PMC: 11653733. DOI: 10.1128/mmbr.00066-22.


Novel humanized anti-PcrV monoclonal antibody COT-143 protects mice from lethal infection via inhibition of toxin translocation by the type III secretion system.

Numata S, Hara T, Izawa M, Okuno Y, Sato Y, Yamane S Antimicrob Agents Chemother. 2024; 68(10):e0069424.

PMID: 39269189 PMC: 11459929. DOI: 10.1128/aac.00694-24.


Evidence for intracellular .

Resko Z, Suhi R, Thota A, Kroken A J Bacteriol. 2024; 206(5):e0010924.

PMID: 38597609 PMC: 11112991. DOI: 10.1128/jb.00109-24.


Propulsive cell entry diverts pathogens from immune degradation by remodeling the phagocytic synapse.

Zhang Z, Gaetjens T, Ou J, Zhou Q, Yu Y, Mallory D Proc Natl Acad Sci U S A. 2023; 120(49):e2306788120.

PMID: 38032935 PMC: 10710034. DOI: 10.1073/pnas.2306788120.


References
1.
Goehring U, Schmidt G, Pederson K, Aktories K, Barbieri J . The N-terminal domain of Pseudomonas aeruginosa exoenzyme S is a GTPase-activating protein for Rho GTPases. J Biol Chem. 1999; 274(51):36369-72. DOI: 10.1074/jbc.274.51.36369. View

2.
Lee V, Schneewind O . Type III machines of pathogenic yersiniae secrete virulence factors into the extracellular milieu. Mol Microbiol. 1999; 31(6):1619-29. DOI: 10.1046/j.1365-2958.1999.01270.x. View

3.
Telepnev M, Schmidt G, Aktories K, Wolf-Watz H, Rosqvist R . GAP activity of the Yersinia YopE cytotoxin specifically targets the Rho pathway: a mechanism for disruption of actin microfilament structure. Mol Microbiol. 2000; 36(3):737-48. DOI: 10.1046/j.1365-2958.2000.01898.x. View

4.
Black D, Bliska J . The RhoGAP activity of the Yersinia pseudotuberculosis cytotoxin YopE is required for antiphagocytic function and virulence. Mol Microbiol. 2000; 37(3):515-27. DOI: 10.1046/j.1365-2958.2000.02021.x. View

5.
Krall R, Schmidt G, Aktories K, Barbieri J . Pseudomonas aeruginosa ExoT is a Rho GTPase-activating protein. Infect Immun. 2000; 68(10):6066-8. PMC: 101576. DOI: 10.1128/IAI.68.10.6066-6068.2000. View